CDK5-dependent phosphorylation of the Rho family GTPase TC10(alpha) regulates insulin-stimulated GLUT4 translocation

J Biol Chem. 2008 Dec 19;283(51):35455-63. doi: 10.1074/jbc.M806531200. Epub 2008 Oct 23.

Abstract

Insulin stimulation results in the activation of cyclin-dependent kinase-5 (CDK5) in lipid raft domains via a Fyn-dependent phosphorylation on tyrosine residue 15. In turn, activated CDK5 phosphorylates the Rho family GTP-binding protein TC10alpha on threonine 197 that is sensitive to the CDK5 inhibitor olomoucine and blocked by small interfering RNA-mediated knockdown of CDK5. The phosphorylation deficient mutant T197A-TC10alpha was not phosphorylated and excluded from the lipid raft domain, whereas the phosphorylation mimetic mutant (T197D-TC10alpha) was lipid raft localized. Insulin resulted in the GTP loading of T197D-TC10alpha but not T197A-TC10alpha and in parallel, T197D-TC10alpha but not T197A-TC10alpha depolymerized cortical actin and inhibited insulin-stimulated GLUT4 translocation. These data demonstrate that CDK5-dependent phosphorylation maintains TC10alpha in lipid raft compartments thereby disrupting cortical actin, whereas subsequent dephosphorylation of TC10alpha through inactivation of CDK5 allows for the re-assembly of F-actin. Because cortical actin reorganization is required for insulin-stimulated GLUT4 translocation, these data are consistent with a CDK5-dependent TC10alpha cycling between lipid raft and non-lipid raft compartments.

MeSH terms

  • 3T3-L1 Cells
  • Actins / genetics
  • Actins / metabolism
  • Animals
  • Cyclin-Dependent Kinase 5 / antagonists & inhibitors
  • Cyclin-Dependent Kinase 5 / genetics
  • Cyclin-Dependent Kinase 5 / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Glucose Transporter Type 4 / genetics
  • Glucose Transporter Type 4 / metabolism*
  • Insulin / genetics
  • Insulin / metabolism
  • Insulin / pharmacology*
  • Kinetin / pharmacology
  • Membrane Microdomains / genetics
  • Membrane Microdomains / metabolism*
  • Mice
  • Phosphorylation / drug effects
  • Phosphorylation / genetics
  • Protein Transport / drug effects
  • Protein Transport / genetics
  • Proto-Oncogene Proteins c-fyn / genetics
  • Proto-Oncogene Proteins c-fyn / metabolism
  • RNA, Small Interfering / genetics
  • rho GTP-Binding Proteins / antagonists & inhibitors
  • rho GTP-Binding Proteins / genetics
  • rho GTP-Binding Proteins / metabolism*

Substances

  • Actins
  • Enzyme Inhibitors
  • Glucose Transporter Type 4
  • Insulin
  • RNA, Small Interfering
  • Slc2a4 protein, mouse
  • olomoucine
  • Fyn protein, mouse
  • Proto-Oncogene Proteins c-fyn
  • Cyclin-Dependent Kinase 5
  • Cdk5 protein, mouse
  • Rhoq protein, mouse
  • rho GTP-Binding Proteins
  • Kinetin